Roy Noy

Roy Noy

Company: Regeneron Pharmaceuticals

Job title: Senior Staff Scientist


Panel Discussion: Combination vs. Single Agent Therapy: What Does the Future Look Like? 4:00 pm

• Discussing the advantages and challenges of single agent vs. combination of myeloid therapies with existing treatment regimens • Highlighting areas of need in combinations based on mechanistic understanding and medical need • Considering the challenges of multi-agent therapy with toxicity and demonstrating added benefit of combination therapy to regulatorsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.